Previous 10 | Next 10 |
2024-01-30 11:30:09 ET More on Utah Medical Products Dividend scorecard for Utah Medical Products Financial information for Utah Medical Products Read the full article on Seeking Alpha For further details see: Utah Medical Products GAAP EPS of $1.18, reve...
SALT LAKE CITY, UT, Jan. 30, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – With Revenues 4% lower and Net Income and Earnings Per Share 1% higher than in 2022, Utah Medical Products, Inc. (Nasdaq: UTMD) achieved financial results for the full year of 2023 consistent with management...
Hang Lung Properties Limited ADR (HLPPY) is expected to report for Q4 2023 Hope Bancorp Inc. (HOPE) is expected to report $0.28 for Q4 2023 Cambridge Bancorp (CATC) is expected to report $0.92 for Q4 2023 RenaissanceRe Holdings Ltd. (RNR) is expected to report $8.13 for Q4 2023 Po...
2023-12-31 10:28:41 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2023-12-28 21:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-11-04 11:08:35 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2023-10-31 10:23:29 ET More on Utah Medical Products Utah Medical Products: Long-Term Positives, But Filshie Clip Overhang Can't Be Ignored Dividend scorecard for Utah Medical Products Financial information for Utah Medical Products For further details see: ...
2023-10-26 12:48:59 ET Utah Medical Products press release ( NASDAQ: UTMD ): Q3 GAAP EPS of $1.08. Revenue of $12.5M (-3.5% Y/Y). For further details see: Utah Medical Products GAAP EPS of $1.08, revenue of $12.5M
SALT LAKE CITY, UT, Oct. 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Utah Medical Products, Inc. [Nasdaq: UTMD], despite a difficult third calendar quarter (3Q), achieved financial results for nine months (9M) 2023 consistent with those anticipated in its beginning of year projecti...
UBS Group AG Registered (UBS) is expected to report for Q3 2023 Capital City Bank Group (CCBG) is expected to report $0.83 for Q3 2023 Boyd Gaming Corporation (BYD) is expected to report $1.44 for Q3 2023 Armstrong World Industries Inc (AWI) is expected to report $1.3 for Q3 2023 ...
News, Short Squeeze, Breakout and More Instantly...
Utah Medical Products Inc. Company Name:
UTMD Stock Symbol:
NASDAQ Market:
Utah Medical Products Inc. Website:
2024-06-25 08:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SALT LAKE CITY, UT / ACCESSWIRE / April 25, 2024 / In the first calendar quarter (1Q) of 2024, Utah Medical Products, Inc. (NASDAQ:UTMD) attained financial results consistent with its previously announced projections for calendar year 2024. Summary of results . The following is a summary com...
Kiniksa Pharmaceuticals Ltd. (KNSA) is expected to report $-0.14 for Q1 2024 Agree Realty Corporation (ADC) is expected to report $1.01 for Q1 2024 1st Colonial Bancorp Inc (FCOB) is expected to report for Q1 2024 Equity Residential of Beneficial Interest (EQR) is expected to report $...